28 September 2018 - The recommendations from the August 2018 PBAC meeting are now available.

The PBAC recommended one medicine (combination product) and one vaccine:

• Budesonide with eformoterol fumarate dihydrate (DuoResp Spiromax/Symbicort Turbuhaler) - restriction change
  
• Meningococcal Groups A, C, W135 & Y conjugate vaccine (Nimenrix) - new indication (new price offer) 
  

Read PBAC outcomes